Related Experiment Video
Updated: Mar 22, 2026
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Lost Labor Productivity Costs of Prostate Cancer to Patients and Their Spouses: Evidence From US National Survey Data
John A Rizzo1, Teresa M Zyczynski, Jie Chen
1Stony Brook University (Dr Rizzo), Stony Brook, New York; Bristol-Myers Squibb (Dr Zyczynski and Dr Penrod), Princeton, New Jersey; University of Maryland School of Public Health (Dr Chen), College Park; CTI Clinical Trial and Consulting, Inc. (Dr Mallow), Cincinnati, Ohio; and Bristol-Myers Squibb (Dr Trudel), Montréal, Québec, Canada.
Objective:
The aim of the study is to estimate lost labor productivity costs of prostate cancer (PC) to patients and their spouses.
Methods:
This study used a nationally representative database from the United States, the Medical Expenditure Panel Survey, to estimate lost productivity costs attributable to PC for patients and their spouses. We used multivariate methods that controlled for sociodemographic factors and comorbid diseases. Sensitivity analyses were used to mitigate the tendency for prevalence rates to be underreported in surveys.
Results:
PC patients had an aggregate national annual lost productivity cost of $5.4 billion ($3601 per individual), whereas their spouses had an aggregate annual lost productivity cost of $3.0 billion ($4013 per individual).
Conclusions:
These results enhance our knowledge of lost labor productivity costs of PC morbidity and may inform the management and treatment of PC from an employer's perspective.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
01:23Infertility in Males
01:21Cancer Survival Analysis